During the past decade, Kursk Regional Clinical Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kursk Regional Clinical Hospital" #1 sponsor was "Celgene" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Supergene, LLC" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kursk Regional Clinical Hospital" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kursk Regional Clinical Hospital" are "Cardiovascular Disease" (2 trials), "Multiple Sclerosis" (2 trials), "Arthritis, Psoriatic" (1 trials), "Coronary Artery Disease" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Kursk Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Kursk Regional Clinical Hospital" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Alteplase" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Alogliptin Benzoate" (1 trials) and "Apremilast (CC-10004)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kursk Regional Clinical Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Kursk Regional Clinical Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Kursk Regional Clinical Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kursk Regional Clinical Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".